News
August 25, 2020

Gilead Says Law Firm’s Ads Misrepresent HIV Drug Suit

Gilead Sciences Inc. has asked a California federal court to admonish a plaintiff’s firm representing people who have taken the anti-HIV drug Truvada and related products, alleging that the firm’s ads regarding the drug’s effects are irresponsible and have harmed those who could benefit from the drug according to a report in Law 360.

Lawyers representing Gilead have asked the court to force Hilliard Martinez Gonzales LLP to admonish Hilliard Martinez for making misleading claims about the health effects of Truvada, and to prohibit the firm from running similar ads in the future.

Ads similar to those done by Hilliard Martinez Gonzales LLP can create serious health consequences for vulnerable individuals, as outlined in ILR’s 2017 research paper. Thus far, three states— Tennessee, Texas, and West Virginia—have enacted legislation to increase transparency in trial lawyer ads.

Blog We Need The Rule of Law, Not Rule of PowerPoint Over-Enforcement News Opinion: “Walmart’s Opioid Whipsaw” Mass Tort Multidistrict Litigation News Attorney Ads Are Driving Paragard IUD Cases Class Action Litigation, Mass Tort Multidistrict Litigation, Trial Lawyer Advertising News In The News Today- Oct. 28, 2020 Class Action Litigation News Australia Securities Class Action Trial Results in Defense Verdict International Initiatives, Securities Litigation Reform
We use cookies to make your experience better:
View Our Privacy Policy